Electromed, Inc. To Participate in the Dougherty & Co. Institutional Investor Conference on September 19, 2017 in Minneapolis

NEW PRAGUE, Minn.--()--Electromed, Inc. (NYSE MKT:ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the Dougherty & Co. Institutional Investor Conference in Minneapolis, Minnesota on September 19, 2017. The conference is taking place at the Millennium Hotel in downtown Minneapolis.

Kathleen Skarvan, President and Chief Executive Officer, and Jeremy Brock, Chief Financial Officer, will be available for one-on-one meetings with attendees throughout the day. To schedule a meeting with management, please contact a Dougherty & Co. representative or The Equity Group, Electromed’s investor relations firm. A copy of management’s presentation will be available in the investor relations section of Electromed’s website at www.smartvest.com.

About Electromed, Inc.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Contacts

Electromed, Inc.
Jeremy Brock, 952-758-9299
Chief Financial Officer
investorrelations@electromed.com
or
The Equity Group Inc.
Kalle Ahl, CFA, 212-836-9614
kahl@equityny.com
or
Devin Sullivan, 212-836-9608
dsullivan@equityny.com

Contacts

Electromed, Inc.
Jeremy Brock, 952-758-9299
Chief Financial Officer
investorrelations@electromed.com
or
The Equity Group Inc.
Kalle Ahl, CFA, 212-836-9614
kahl@equityny.com
or
Devin Sullivan, 212-836-9608
dsullivan@equityny.com